ANDA 76413, held by Ranbaxy Labs Ltd. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 76413 (Metformin Hydrochloride), held by Ranbaxy Labs Ltd, was not approved, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 31, 2003 | Original application | Tentative approval |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metformin Hydrochloride500MG ยท tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
| Apr 16, 2007 | Supplement 10Manufacturing | Approved | None posted |
| Oct 31, 2003 | Original application | Tentative approval |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters